Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP
  • Is it time for Medi-change?

    Medical Journal of Australia Date published:
  • HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

    Cochrane Database of Systematic Reviews Date published:
  • The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy

    Journal of the American Society of Nephrology Date published:
  • Kidney Disease in Diabetes

    Managing Cardiovascular Complications in Diabetes Date published:
  • HMG CoA reductase inhibitors (statins) for kidney transplant recipients

    Cochrane Database of Systematic Reviews Date published:
  • Authors' reply to Ladapo and Ogedegbe

    BMJ Date published:
  • DIETARY SODIUM REDUCTION REDUCED ALBUMINURIA IN 1,903 RURAL CHINESE: A CLUSTER RANDOMISED TRIAL

    Date published:
  • Long-term Efficacy and Safety of Linagliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Disease

    Date published:
  • RESEARCH PRIORITIES IN CHRONIC KIDNEY DISEASE: A PRIORITY SETTING PARTNERSHIP

    Date published:
  • Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network

    Kidney International Date published:
  • HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

    Sao Paulo Medical Journal Date published:
  • Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy

    American Journal of Nephrology Date published:
  • kidney disease in diabetes

    Managing Cardiovascular Complications in Diabetes Date published:
  • THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL

    Nephrology Date published:
  • INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Nephrology Date published:
  • A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL

    Nephrology Date published: